(Q39837123)

15 September 2017

title

A complex role of activin A in non-alcoholic fatty liver disease (English)

1 reference

non-alcoholic fatty liver

15 September 2017

main subject

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

15

Pål Aukrust

0 references

Jan Kristian Damås

7

object named as

Jan Kristian Damås

0 references

Ivar Prydz Gladhaug

5

object named as

Ivar Prydz Gladhaug

1 reference

15 September 2017

13

Bente Halvorsen

1 reference

15 September 2017

1

Arne Yndestad

1 reference

15 September 2017

John Willy Haukeland

2

1 reference

15 September 2017

Tuva Børresdatter Dahl

3

1 reference

15 September 2017

Kristian Bjøro

4

1 reference

15 September 2017

Christ Berge

6

1 reference

15 September 2017

Terese Haaland

8

1 reference

15 September 2017

Else Marit Løberg

9

1 reference

15 September 2017

Paul Linnestad

10

1 reference

15 September 2017

Kåre Birkeland

11

1 reference

15 September 2017

Zbigniew Konopski

12

1 reference

15 September 2017

Rolf Kristian Berge

14

1 reference

15 September 2017

language of work or name

English

0 references

publication date

16 June 2009

1 reference

The American Journal of Gastroenterology

15 September 2017

published in

1 reference

15 September 2017

volume

104

1 reference

15 September 2017

issue

9

1 reference

15 September 2017

page(s)

2196-2205

1 reference

https://scigraph.springernature.com/pub.10.1038/ajg.2009.318

15 September 2017

exact match

0 references

cites work

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Long term prognosis of fatty liver: risk of chronic liver disease and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

The transforming growth factor-beta superfamily of receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Roles of activin in tissue repair, fibrosis, and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Activin A augments vascular endothelial growth factor activity in promoting branching tubulogenesis in hepatic sinusoidal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

The activin axis in liver biology and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

The effect of fasting on the activity of liver carnitine palmitoyltransferase and its inhibition by malonyl-CoA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Molecular mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

A lipidomic analysis of nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Transforming growth factor-beta 1, activin and follistatin in patients with hepatocellular carcinoma and patients with alcoholic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Characterization of serum activin-A and follistatin and their relation to virological and histological determinants in chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Activin A and follistatin in systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Activin A regulates growth and acute phase proteins in the human liver cell line, HepG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Potential anti-inflammatory role of activin A in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Matrix metalloproteinases, the pros and cons, in liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Matrix as a modulator of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Antifibrotic agents for liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Elevated levels of activin A in heart failure: potential role in myocardial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

The ins and outs of mitochondrial dysfunction in NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Fatty acid import into mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Hepatic free fatty acids accumulate in experimental steatohepatitis: role of adaptive pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.318

21 January 2018

Identifiers

DOI

10.1038/AJG.2009.318

1 reference

Dimensions Publication ID

15 September 2017

1023987625

0 references

1 reference